Isolated Supratentorial Intraventricular Recurrence of Medulloblastoma

Article information

J Korean Neurosurg Soc. 2015;58(6):557-559
Publication date (electronic) : 2015 December 31
doi : https://doi.org/10.3340/jkns.2015.58.6.557
1Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
2Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Address for reprints: Kingsley O. Abode-Iyamah, M.D. Department of Neurosurgery, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52245, USA. Tel: +1-(011) 319-356-1616, Fax: +1-(011) 319-353-6605, kingsley-abode-iyamah@uiowa.edu
Received 2014 July 25; Revised 2014 November 25; Accepted 2014 November 25.

Abstract

Medulloblastoma is a common pediatric tumor typically diagnosed before the age of fifteen. Initial therapy includes surgical resection and radiation of the entire neuro-axis. Recurrence is common and typically occurs within 2 years of initial diagnosis. Those fitting Collin's Law is considered tumor-free. We report a case of single supratentorial recurrence 13 years after initial diagnosis. Here we present a 22 year old male presenting 13 years after initial diagnosis with isolated septum pellucidum recurrence. He underwent complete resection of the tumor. Medulloblastoma is a common in the pediatric population. Late recurrence to the ventricular system is uncommon. Long term follow-up is recommended in these patients.

INTRODUCTION

Medulloblastoma (MB) is the most common malignant tumor in children, accounting for 15 to 25% of all childhood brain tumors192021). Occurrence in the adult population is also well documented, but only accounts for 1% of adult tumors11). Treatment includes surgical resection followed by radiotherapy of the entire neuro-axis and chemotherapy451923).

Recurrence of this tumor is well recognized and may require salvage therapy. Time to recurrence typically occurs within two years of initial diagnosis in the pediatric population. Tumors that follow Collin's Law (tumor free period of 9 months plus the age at diagnosis) are considered to be cured11920). However, late recurrence of MB has been documented in the pediatric population23121323).

The locations of recurrences most commonly present as posterior fossa, spinal, supratentorial, or boney metastases23). Supratentorial recurrence is reported to be more common in the subfrontal region1923), while late recurrence of MB in the supratentorial intraventricular compartment is rare17).

CASE REPORT

History

A 22-year-old male with a history of a medulloblastoma at 9 years of age, removed surgically and treated with adjuvant craniospinal irradiation and chemotherapy presented with 2.5 weeks of progressive gait ataxia and headache.

Examination

Patient was alert and oriented. The right pupil was sluggish. The left pupil was reactive and the left eye deviated uncontrollably on exam. The left upper extremity had 4/5 strength. CT scan showed an anterior septum pellucidum mass at the foramen of Monro with secondary obstructive hydrocephalus (Fig. 1).

Fig. 1

CT brain without contrast (B) showing a septal lesion causing obstruction of the foramen Monro resulting in obstructive hydrocephalus. (A) MRI of the brain without contrast on 7/14/2009 last scan prior to recent presentation.

Post-operative course

The patient underwent bilateral ventriculostomy and external ventricular drain placement with subsequent tumor resection (Fig. 2, 3). Pathology report was consistent with anaplastic/large-cell medulloblastoma (Fig. 4).

Fig. 2

MRI with contrast axial (A), sagittal (B), and coronal (C) showing a homogenously enhancing septal mass obstructing the foramen Monro.

Fig. 3

MRI with contrast axial (A), sagittal (B), and coronal (C) showing right transcortical intraventricular approach for tumor resection. Gross tumor resection was accomplished.

Fig. 4

A : Diffuse infiltrate of small to large pleomorphic cells with little cytoplasm (synaptophysin positive). B : High power view. Cells have hyperchromatic angular nuclei. Cell wrapping, a feature commonly found in anaplastic/large cell MB (white arrow).

DISCUSSION

Medulloblastoma, a malignant tumor typically arising from the cerebellar vermis in young children and lobes in older children, represents 4–8% of all intracranial tumors, and is the most common malignant central nervous system tumor of childhood192021), with approximately 80% occurring in patients under 15 years of age21). It accounts for 15–25% of all childhood brain tumors in comparison with only 1% of adult intracranial neoplasms, with a slight male predominance in both groups1920212324).

Presenting features of medulloblastoma are generally related to hydrocephalus (found radiographically in 97% of patients) and cerebellar dysfunction which include : headache, nausea/vomiting, truncal ataxia, and unsteady gait23). Approximately 83% are found in the midline in children, while 49% of adult tumors are lateral21).

Differences in childhood and adult tumors can also be observed in terms of histologic variant. Classical histologic presentation of medulloblastoma includes densely-packed primitive cells with hyperchromatic nuclei, scant cytoplasm, and nuclear molding120). This classical tumor histology is more common in children821). Homer-Wright rosettes may be seen10). Adults are more likely to have laterally-located tumors, which more often desmoplastic51021). Both tumor types include markers of neuronal lineage, such as class III beta tubulin and MAP-2 neurofilaments, whereas more adult tumors will express GFAP1020). The anaplastic/ large cell variant is more frequently seen in older children and adults.

MB tends to seed the cerebrospinal fluid resulting in extensive leptomeningeal involvement, and treatment therefore requires surgical resection followed by neuro-axis radiotherapy and chemotherapy7171923). Recurrence in the pediatric population differs from that seen in adults. Age at diagnosis has been shown to be a significant predictor of time until relapse24). The majorities of pediatric recurrences are within two years of initial diagnosis, and are in the posterior fossa192024). Those with tumor-free period equal to the age at diagnosis plus nine months may be considered cured (Collin's Law)14181920). While a good predictor of many childhood tumors, there are known exceptions to Collins law for MB1269131822). However, a recent review of 125 patients by Massimino et al.1415), gender, age at diagnosis, metastases, and therapeutic protocol were shown to have no prognostic impact.

In the event of recurrence, relapse at a single site and further out from initial time of diagnosis is considered a more favorable prognostic indicator15). Recurrences are most common in the posterior fossa, followed by spinal, supratentorial and boney metastases23). Supratentorial dissemination is often found in the subfrontal area and may be due to overly generous radiation protection of the orbital roof to prevent irradiation of the cribiform plate, allowing for a nidus of recurrence16). Late recurrence of MB in the supratentorial ventricular compartment is uncommon. We present a case of late recurrent MB 13 years after initial diagnosis, again validating the need for long term follow-up in the pediatric population following diagnosis of MB.

CONCLUSION

Recurrence of MB is common and often occurs in the posterior fossa. Supratentorial dissemination of MB is more common in the subfrontal region. Supratentorial recurrence of MB not following Collin's Law is extremely uncommon, especially within the supratentorial ventricular system. We present a case of a 22 years old male who presented 13 years following his initial diagnosis of MB with symptoms of obstructive hydrocephalus from a septum pellucidum recurrence. Continued close follow-up is need in pediatric patients after resection and radiation for MB given their unexpected recurrence pattern.

References

1. Allan R, Gill A, Spittaler P. Recurrent medulloblastoma--violation of Collin's law by 14 years. J Clin Neurosci 2004;11:756–757. 15337141.
2. Amagasaki K, Yamazaki H, Koizumi H, Hashizume K, Sasaguchi N. Recurrence of medulloblastoma 19 years after the initial diagnosis. Childs Nerv Syst 1999;15:482–485. 10502011.
3. Belza MG, Donaldson SS, Steinberg GK, Cox RS, Cogen PH. Medulloblastoma : freedom from relapse longer than 8 years--a therapeutic cure? J Neurosurg 1991;75:575–582. 1885975.
4. Brown WD, Tavaré CJ, Sobel EL, Gilles FH. Medulloblastoma and Collins' law : a critical review of the concept of a period of risk for tumor recurrence and patient survival. Neurosurgery 1995;36:691–697. 7596498.
5. Buglione M, Triggiani L, Grisanti S, Liserre R, Buttolo L, Gipponi S, et al. Retreatment of recurrent adult medulloblastoma with radiotherapy : a case report and review of the literature. J Med Case Rep 2013;7:64. 23497715.
6. Cieślak E, Kepka L, Fijuth J, Marchel A, Kroh H. Very late relapse of medulloblastoma. Folia Neuropathol 2004;42:49–53. 15119746.
7. David KM, Casey AT, Hayward RD, Harkness WF, Phipps K, Wade AM. Medulloblastoma : is the 5-year survival rate improving? A review of 80 cases from a single institution. J Neurosurg 1997;86:13–21. 8988076.
8. Ferrante L, Mastronardi L, Celli P, Acqui M, Cervoni L, Fortuna A. Medulloblastoma in adulthood. J Neurosurg Sci 1991;35:23–30. 1890457.
9. Friedberg MH, David O, Adelman LS, Heilman CB. Recurrence of medulloblastoma : violation of Collins' law after two decades. Surg Neurol 1997;47:571–574. 9167782.
10. Giordana MT, Cavalla P, Dutto A, Borsotti L, Chiò A, Schiffer D. Is medulloblastoma the same tumor in children and adults? J Neurooncol 1997;35:169–176. 9266455.
11. Giordana MT, Schiffer P, Lanotte M, Girardi P, Chio A. Epidemiology of adult medulloblastoma. Int J Cancer 1999;80:689–692. 10048968.
12. Hardy DG, Hope-Stone HF, McKenzie CG, Scholtz CL. Recurrence of medulloblastoma after homogeneous field radiotherapy. Report of three cases. J Neurosurg 1978;49:434–440. 682006.
13. King GA, Sagerman RH. Late recurrence in medulloblastoma. Am J Roentgenol Radium Ther Nucl Med 1975;123:7–12.
14. Massimino M, Antonelli M, Gandola L, Miceli R, Pollo B, Biassoni V, et al. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators. Pediatr Blood Cancer 2013;60:210–216. 22693015.
15. Massimino M, Casanova M, Polastri D, Biassoni V, Modena P, Pecori E, et al. Relapse in medulloblastoma : what can be done after abandoning high-dose chemotherapy? A mono-institutional experience. Childs Nerv Syst 2013;[Epub ahead of print].
16. Miralbell R, Bleher A, Huguenin P, Ries G, Kann R, Mirimanoff RO, et al. Pediatric medulloblastoma : radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys 1997;37:523–529. 9112448.
17. Nigri F, Telles C, Acioly MA. Late obstruction of an endoscopic third ventriculostomy stoma by metastatic seeding of a recurrent medulloblastoma. J Neurosurg Pediatr 2010;5:641–644. 20515341.
18. Nishio S, Morioka T, Takeshita I, Fukui M. Medulloblastoma : survival and late recurrence after the Collins' risk period. Neurosurg Rev 1997;20:245–249. 9457719.
19. Roka YB, Bista P, Sharma GR, Adhikari D, Kumar P. Frontal recurrence of medulloblastoma five years after excision and craniospinal irradiation. Indian J Pathol Microbiol 2009;52:383–385. 19679968.
20. Sanders MA, Vitaz T, Rosenblum M, Plaga AR, Parker JC Jr, Parker JR. 46-year-old man with a spinal cord mass. Brain Pathol 2011;21:109–112. 21129065.
21. Sarkar C, Pramanik P, Karak AK, Mukhopadhyay P, Sharma MC, Singh VP, et al. Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index. J Neurooncol 2002;59:49–61. 12222838.
22. Stevens B, Razzaqi F, Yu L, Craver R. Late recurrence of medulloblastoma. J La State Med Soc 2008;160:138–141. 18655650.
23. Sun LM, Yeh SA, Wang CJ, Huang EY, Chen HC, Hsu HC, et al. Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region. J Neurooncol 2002;58:77–85. 12160144.
24. Tabori U, Sung L, Hukin J, Laperriere N, Crooks B, Carret AS, et al. Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma. Int J Radiat Oncol Biol Phys 2006;64:402–407. 16198067.

Article information Continued

Fig. 1

CT brain without contrast (B) showing a septal lesion causing obstruction of the foramen Monro resulting in obstructive hydrocephalus. (A) MRI of the brain without contrast on 7/14/2009 last scan prior to recent presentation.

Fig. 2

MRI with contrast axial (A), sagittal (B), and coronal (C) showing a homogenously enhancing septal mass obstructing the foramen Monro.

Fig. 3

MRI with contrast axial (A), sagittal (B), and coronal (C) showing right transcortical intraventricular approach for tumor resection. Gross tumor resection was accomplished.

Fig. 4

A : Diffuse infiltrate of small to large pleomorphic cells with little cytoplasm (synaptophysin positive). B : High power view. Cells have hyperchromatic angular nuclei. Cell wrapping, a feature commonly found in anaplastic/large cell MB (white arrow).